| 期 |
标题 |
文件 |
| 卷 7, 编号 2 (2025) |
Dedicated to the memory of Professor Vladislav A. Kraus, a leading figure in neuropharmacology |
(Rus)
|
|
Okovityi S., Napalkova S., Ivkin D., Dyachkova E.
|
| 卷 2, 编号 3 (2020) |
Conference "Young pharmacy – the potential of the future» |
(Rus)
|
|
Narkevich I.
|
| 卷 2, 编号 3 (2020) |
Bioindication of the ecological state (health) of coastal waters based on the use of automatic bioelectronic systems |
(Eng)
|
|
Kholodkevich S., Kuznetsova T., Kirin M., Smirnov I., Rudakova O., Lyubimtsev V., Manvelova A., Susloparova O., Perelygin V., Sakharova O.
|
| 卷 2, 编号 2 (2020) |
Gravicentric approach to Type 2 Diabetes therapy.
The success prediction. A proof-of-concept |
(Eng)
|
|
levit S., Torban N., Boaz M., Weichman M., Azuri J., Manisterski Y., Merzon E., Ryder D., Ginossar G., Gavra T., Levit V., Domuschiev I., Musin I., Ryder C.
|
| 卷 3, 编号 1 (2021) |
Inonotus rickii (瑞克纤孔菌) 提取物对肌肉收缩强度影响的评估 |
(简体中)
(Rus)
|
|
Ranadive K.., Jagtap N.V., Jagtap P.N., Zmitrovich I.V., Perelygin V.V.
|
| 卷 2, 编号 2 (2020) |
THE POSSIBILITY OF USING PICTOPOLYGRAPHY IN THE OBJECTIVE DIAGNOSIS OF AFFECTIVE DISORDERS |
(Eng)
|
|
Shamrey V., Baurova N., Kurasov E., Svechnikov D., Medvedeva J.
|
| 卷 2, 编号 3 (2020) |
Alexander Stepanovich Ardemasov: Party director of the Leningrad Pharmaceutical Institute in 1940-1942 |
(Rus)
|
|
Narkevich I., Stepanov S., Volgusheva A., Zvyagin Y., Vorobeva S., Perelygin V., Dobrova D.
|
| 卷 1, 编号 1 (2019) |
Alopecia: from clinic to preclinic and back |
(Rus)
|
|
Ivkin D., Nogaeva U., Flisyuk E., Pisetskaya M., Shtyrlin Y.
|
| 卷 1, 编号 1 (2019) |
A unified and simplified flow diagram of the production of active pharmaceutical ingredients and the finished dosage form |
(Rus)
|
|
Gabidova A., Galynkin V.
|
| 卷 2, 编号 3 (2020) |
Analysis of the level and dynamics of prices in the pharmaceutical market of Saint Petersburg |
(Rus)
|
|
Orlov A., Kocherba M.
|
| 卷 2, 编号 2 (2020) |
COMPARISON OF REQUIREMENTS OF ANNEX 1 TO THE RULES OF GOOD MANUFACTURING PRACTICE OF THE EURASIAN ECONOMIC UNION AND REQUIREMENTS OF THE DRAFT ANNEX 1 GMP PIC/S |
(Rus)
|
|
Basevich A., Kaukhova I., Kodash A., Bitkina T., Smirnova E., Stepchenkov V.
|
| 卷 2, 编号 3 (2020) |
SUPPORTING DEVICES IN THE TREATMENT OF CHRONIC HEART FAILURE IN ELDERLY AND OLD PATIENTS |
(Rus)
|
|
Hubulava G., Kozlov K., Bogomolov A., Volkov A., Fedorets V., Senkina E.
|
| 卷 1, 编号 1 (2019) |
Continuous glucose monitoring - proved hypoglycemia in sodium-glucose co-transporter-2 inhibitors - treated type 2 diabetes patients: a link to ketosis development |
(Eng)
|
|
Levit S., Giveon S., Musin I., Barnea R., Korek-Abadi I., Levit V., Ryder D., Ryder C.
|
| 卷 2, 编号 2 (2020) |
Grigory Yakovlevich Kogan: Director of the Leningrad Pharmaceutical Institute in 1938-1941 |
(Rus)
|
|
Narkevich I., Stepanov S., Zvyagin Y., Vorobeva S., Perelygin V., Dobrova D.
|
| 卷 2, 编号 3 (2020) |
Malignant neoplasms of the heart, prevalence, weather mortality, median survival and survival of patients, taking into account the stage of diseases, localization and histological structure of tumors |
(Rus)
|
|
Merabishvili V.
|
| 卷 2, 编号 3 (2020) |
Study of international experience in research of professional activity of pharmaceutical personnel in the context of restrictions,
related to the development of the system of professional qualifications in the Russian Federation |
(Rus)
|
|
Ivanova K., Ilinova J.
|
| 卷 1, 编号 1 (2019) |
Discharge Inventory: A New Duty |
(Rus)
|
|
Subbotinskaya V.
|
| 卷 1, 编号 1 (2019) |
Rabbit models of ischemic stroke in biomedical research |
(Rus)
|
|
Sysoev Y., Prikhodko V., Ivkin D., Okovity S.
|
| 卷 2, 编号 3 (2020) |
Cariprazine is a modern antipsychotic with a favorable neuroendocrine profile |
(Rus)
|
|
Dorovskikh I., Pavlova T., Scheidegger J.
|
| 卷 2, 编号 3 (2020) |
Laser synthesis of nanomaterials to create a new family of electrochemical microbiosensors |
(Rus)
|
|
Kochemirovskaya S., Novomlinsky M., Fogel A., Kochemirovsky V.
|
| 卷 2, 编号 3 (2020) |
About creation of a hybrid multi-level atmospheric air monitoring system in the Republic of Tatarstan |
(Rus)
|
|
Trofimov O., Rubezhov A., Kraft M., Udaltsov A.
|
| 卷 2, 编号 3 (2020) |
Review and revision of the tribe Baphieae Yakovl. (Fabaceae) |
(Rus)
|
|
Gonharov M., Yakovlev G.
|
| 卷 1, 编号 1 (2019) |
He created a modern pharmacologist |
(Rus)
|
|
Narkevich I., Zvyagin Y., Vorobieva S., Perelygin V., Dobrova D.
|
| 卷 2, 编号 2 (2020) |
Determination of the marker compounds for standardization medicinal herbal species «Pectorales tea №1» and «Proctofitol» |
(Rus)
|
|
Terninko I., Vishnyakov E., Romanova M., Generalova Y.
|
| 卷 2, 编号 3 (2020) |
Organization of practical training on the circulation of labeled drugs at the Saint Petersburg State Chemical and Pharmaceutical University |
(Rus)
|
|
Siukaeva D.
|
| 卷 1, 编号 1 (2019) |
Features of regulation and control of emissions at the facility of category III |
(Rus)
|
|
Lamikhova M.
|
| 卷 2, 编号 2 (2020) |
From the editor |
(Rus)
|
|
Perelygin V.
|
| 卷 2, 编号 3 (2020) |
FROM THE EDITOR |
(Rus)
|
|
Flisyuk E.
|
| 卷 2, 编号 2 (2020) |
Pathogenetic mechanisms of antinociceptive activity of antidepressants |
(Rus)
|
|
Scheidegger J., Dorovskiкh I., Pavlova T.
|
| 卷 1, 编号 1 (2019) |
Approaches to a comprehensive solution to the problem of medical waste management |
(Rus)
|
|
Perelygin V., Sklyarova N., Paramonov S., Pyatizbyantsev T.
|
| 卷 2, 编号 3 (2020) |
Teaching the Humanities and Social Sciences at the Petrograd (Leningrad) Chemical-Pharmaceutical Institute in the 1920s |
(Rus)
|
|
Narkevich I., Stepanov S., Zvyagin Y., Vorobeva S., Perelygin V., Dobrova D.
|
| 卷 1, 编号 1 (2019) |
Creating new drugs design patterns.Step one.
Pharmaceutical development |
(Rus)
|
|
Basevich A., Dzjuba A., Kaukhova I., Andreeva P.
|
| 卷 2, 编号 2 (2020) |
Sergey Kholodkevich: "I quite often came up with original ideas, which then turned out to be in demand» |
(Rus)
|
|
Zvyagin Y.
|
| 卷 2, 编号 2 (2020) |
Retraction Notice Gabidova A., Galynkin V. A unified and simplified flow diagram of the production of active pharmaceutical ingredients and the finished dosage form // Pharmacy Formulas. - 2019. - Т. 1. - №1. - C. 32-37. doi: 10.17816/phf18552 |
(Rus)
|
|
Gabidova A., Galynkin V.
|
| 卷 2, 编号 2 (2020) |
Structural analysis of drugs assortment for etiopathogenetic therapy of children with acute viral infections |
(Rus)
|
|
Narkevich I., Nemyatykh O., Timchenko V., Siukaeva D., Terninko T., Alekseeva V.
|
| 卷 1, 编号 1 (2019) |
Tendencies and perspectives of central alpha2-adrenomimetic application in medicobiological research |
(Eng)
|
|
Vengerovich N., Ivanov I., Proshina Y.
|
| 卷 2, 编号 3 (2020) |
Course of intrahospital coronavirus infection (COVID-19) against the background of preventive and curative administration of peptide immunotropic drugs as part of complex therapy |
(Rus)
|
|
Petlenko S., Smirnov V., Rudenko V.
|
| 卷 1, 编号 1 (2019) |
Pharmacists in the system of pediatric palliative care: international practice and prospects in Russia |
(Rus)
|
|
Narkevich I., Nemyatykh O., Medvedeva D.
|
| 卷 2, 编号 2 (2020) |
Chaga and its bioactive complexes: history and perspectives |
(Rus)
|
|
Zmitrovich I., Denisova N., Balandaykin M., Belova N., Bondartseva M., Perevedentseva L., Perelygin V., Yakovlev G.
|
| 卷 2, 编号 2 (2020) |
Experimental study of the liposomal form of fenoterol after improving the method of obtaining it |
(Rus)
|
|
Ustinova T., Vengerovich N., Judin M.
|
| 卷 2, 编号 2 (2020) |
Electronic workflow for healthcare |
(Rus)
|
|
Kiryushkin S.
|
| 卷 3, 编号 1 (2021) |
俄罗斯和俄罗斯联邦西北区肿瘤科客观评估系统的发展阶段 （恶性肿瘤患者发病率、死亡率、登记可靠性、年死亡率、中位生存期、观察存活率和相对存活率），第二部分。 |
(简体中)
(Rus)
|
|
Merabishvili V.M., Belyaev A.M.
|
| 卷 3, 编号 1 (2021) |
俄罗斯和俄罗斯联邦西北区肿瘤科活动客观评估系统的发展阶段 （恶性肿瘤患者发病率、死亡率、登记可靠性、年死亡率、中位存活期、观察存活率和相对存活率），第一部分。 |
(简体中)
(Rus)
|
|
Merabishvili V.M., Belyaev A.M.
|
| 201 - 243 的 243 信息 |
<< < 1 2 3 |
